Former Medtronic CEO Bill Hawkins has landed at blood screening and equipment company Immucor.Hawkins spent three years leading Medtronic. He was originally expected to retire from the company in April 2011, but postponed his retirement while the company’s board of directors sought a successor. Former GE Healthcare Systems CEO Omar Ishrak took Hawkins’ place [...]

They gave him a sword and he handed them the world.When William Hawkins officially flipped the keys to Medtronic Inc. (NYSE:MDT) over to successor Omar Ishrak, he offered a simple message and a gift. The message was clear ’ don’t lose sight of founder Earl Bakken’s mission to alleviate pain, restore health [...]

Williams Hawkins, the former CEO of Medtronic Inc. (NYSE:MDT), pulled down $5.5 million in salary and benefits during fiscal 2011, according to a regulatory filing.Hawkins stands to do pretty well this year too, as his severance package includes a deal to stay on for fiscal 2012 at the same pay rate, according to [...]

Medtronic Inc. has lured away the President and CEO of GE Healthcare Systems Omar Ishrak to replace current Chairman and CEO Bill Hawkins, who is retiring. Come June 13, Ishrak will take over running the world’s largest medical device company, based in Fridley, Minnesota.GE Healthcare Systems is a $12 billion division of GE Healthcare and [...]

What to make of Medtronic (NYSE:MDT) CEO Bill Hawkins’ decision to postpone his retirement?A spokesman for the Fridley, Minnesota-based company declined to answer any questions about the search for a new CEO. But one thing is clear: something transpired between Feb. 22, when Hawkins told analysts it would be the last time he would lead [...]

Medtronic Chairman and CEO Bill Hawkins sent a note to employees Monday saying that he will stay on longer than he initially intended because the search for his successor is taking longer than expected.Hawkins was expected to retire at the end of fiscal year 2011, which ended in late April. But on Monday, he told [...]

Medtronic Inc. (NYSE: MDT) says it’s resolved U.S. Food and Drug Administration warning letter issues at two manufacturing facilities — clearing the way for new product launches.

Medtronic is on the hunt for a new CEO to replace Bill Hawkins. Could a current board member be the chosen one?

Medtronic Inc. (NYSE:MDT) will fund a clinical trial for Nile Therapeutics Inc. (NSDQ:NLTX) behind a peptide treatment for heart failure. The San Mateo, Calif. biopharmaceutical company said Medtronic will also provide expertise on building a drug-device combination as Nile completes a Phase I trial to “assess the pharmacokinetics and phamacodynamics of cenderitide delivered through Medtronic diabetes pump technology,” according to a prepared release.

How quickly new innovative medical devices get to market will be determined in part by changes in the U.S. Food and Drug Administration’s 510(k) program. Outgoing Medtronic (NYSE:MDT) Chief Executive Bill Hawkins said this week that updates to 510(k) “will be neutral to slightly negative.”